Plus   Neg

Merck Announces Approval For KEYTRUDA In Adjuvant Setting In European Union

Merck (MRK) announced the European Commission has approved KEYTRUDA, the company's anti-PD-1 therapy, for the adjuvant treatment of adults with stage III melanoma and lymph node involvement who have undergone complete resection. The approval allows marketing of KEYTRUDA in this new indication in all 28 EU member states plus Iceland, Lichtenstein and Norway. KEYTRUDA is also approved in Europe as a monotherapy for the treatment of advanced (unresectable or metastatic) melanoma in adults.

Scot Ebbinghaus, vice president, clinical research, Merck Research Laboratories, said: "This approval, which is the first for KEYTRUDA in the adjuvant setting in the European Union, builds upon the foundation established by KEYTRUDA in the advanced and metastatic melanoma settings."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Deutsche Telekom AG were losing around 2 percent in German trading after the telecom giant reported Thursday a net loss in its fourth quarter, compared to prior year's profit, despite increased revenues. Looking ahead, the company said its 2019 forecast shows undiminished growth momentum. Hormel Foods Corp. on Thursday reported a 20 percent decline in profit for the first quarter from last year, when results were aided by a benefit related to the U.S. tax reform. However, earnings per share for the quarter matched analysts' expectations, while revenues missed their estimates. Looking ahead, the branded food company reiterated its financial outlook for fiscal 2019. Southwest Airlines Co. said it will investigate whether a dispute with its mechanics union was the cause of an "unprecedented number" of out-of-service aircraft that resulted in flight cancellations and flight delays. Southwest Airlines COO Mike Van de Ven said in a statement that the airline has been negotiating with Aircraft Mechanics Fraternal Association or AMFA for more than six years.
Follow RTT